Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 12:27:100732.
doi: 10.1016/j.ymgmr.2021.100732. eCollection 2021 Jun.

Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations

Affiliations

Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations

F Ozkinay et al. Mol Genet Metab Rep. .

Abstract

Aim: Mucopolysaccharidosis type III B (MPS IIIB) is an autosomal recessive lysosomal storage disease caused by mutations in the NAGLU gene which codes the lysosomal enzyme alpha-N-acetylglucosaminidase. The major symptoms of the disease are cognitive and neurological defects. In this study, the molecular spectrums of 13 MPS IIIB patients were evaluated.

Material and methods: Thirteen MPS IIIB patients from 11 families were included in this study. All patients were both clinically and molecularly diagnosed. NAGLU gene sequencing was performed using a next generation sequencing platform (Illumina MiSeq). Demographic, clinical and laboratory findings of the patients were obtained via the hospital records.

Results: Ten different mutations from the 13 MPS IIIB patients were identified. Eight of the 10 mutations were missense, one was splice site, and one large deletion was also observed. Two mutations c.509G>T (p.Gly170Val) and c.700C>G (p.Arg234Gly) have been defined for the first time in this study.

Conclusion: Our study expanded the mutation spectrum of the NAGLU gene thereby contributing to the improved genetic counselling of MPS IIIB patients. Confirming the literature, missense mutations were also found to be the most common NAGLU mutations in our study.

Keywords: Mucopolysaccaridosis; NAGLU; Sanflippo syndrome.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

References

    1. Fedele A.O. Sanfilippo syndrome: causes, consequences, and treatments. Appl. Clin. Genet. 2015;8:269–281. - PMC - PubMed
    1. Kim Y.-E., Park H.-D., Jang M.-A., Ki C.-S., Lee S.-Y., Kim J.-W. A novel mutation (c.200T>C) in the NAGLU gene of a Korean patient with mucopolysaccharidosis IIIB. Ann Lab Med. 2013 May;33(3):221–224. - PMC - PubMed
    1. Valstar M.J., Bruggenwirth H.T., Olmer R., Wevers R.A., Verheijen F.W., Poorthuis B.J. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J. Inherit. Metab. Dis. 2010 Dec;33(6):759–767. - PMC - PubMed
    1. Moog U., van Mierlo I. Van Schrojenstein Lantman-de Valk HMJ, Spaapen L, Maaskant MA, Curfs LMG. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am. J. Med. Genet. C: Semin. Med. Genet. 2007 Aug 15;145C(3):293–301. - PubMed
    1. 2019. https://www.ncbi.nlm.nih.gov/books/NBK546574/

LinkOut - more resources